Loss of SMARCA4 is necessary for this hypersensitivity, but as re-expressing SMARCA4 in a cancer cell line lacking it only partially rescued cells from AURKA knockdown, SMARCA4 loss is not sufficient for this sensitivity. The gene discussed is SMARCA4; the disease is cancer.